Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/3fXZVBo8NHU/236391.php
Friday, 21 October 2011
Targeting Redness Of Rosacea - Investigational Gel Shows Promise In Human Trial
At least 16 million Americans suffer from Rosacea, a chronic dermatological skin condition of the face involving persistent redness, flushing, inflammatory lesions and visible blood vessels. An announcement made today by Galderma Pharma S.A., reports positive top-line results from a Phase 2b trial regarding the efficacy and safety of CD07805/47, a proprietary topical gel under investigation for treating patients with moderate to severe facial erythema (redness) of rosacea. Joseph F. Fowler, M.D...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment